(Q48897507)

16 February 2018

title

Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. (English)

1 reference

16 February 2018

author

Paul D. Wes

2

1 reference

16 February 2018

Nataša Hlaváčová

1

object named as

Natasa Hlavacova

1 reference

16 February 2018

author name string

Maria Ondrejcakova

3

1 reference

16 February 2018

Marianne E Flynn

4

1 reference

16 February 2018

Patricia K Poundstone

5

1 reference

16 February 2018

Stanislav Babic

6

1 reference

16 February 2018

Harald Murck

7

1 reference

16 February 2018

Daniela Jezova

8

1 reference

16 February 2018

publication date

4 March 2011

1 reference

16 February 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

16 February 2018

volume

15

1 reference

16 February 2018

issue

2

1 reference

16 February 2018

page(s)

247-265

1 reference

16 February 2018

Endocrine factors in stress and psychiatric disorders: focus on anxiety and salivary steroids

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Positive effects of captopril in the behavioral despair swim test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Aldosterone-sensitive neurons in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Analysis of IL-1alpha, IL-1beta, and IL-1RA [correction of IL-RA] polymorphisms in dysthymia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Increased plasma aldosterone in patients with clinical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Roles of glial cells in synapse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

The Renin-Angiotensin-Aldosterone system in patients with depression compared to controls – a sleep endocrine study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Magnesium and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Effect of environmental enrichment on stress related systems in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Treatment-resistant depression: recent developments and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Modulation of neuroendocrine response and non-verbal behavior during psychosocial stress in healthy volunteers by the glutamate release-inhibiting drug lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

The genetics of depression: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Sickness behavior as a new target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

GABA and glutamate systems as therapeutic targets in depression and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Regionally selective and dose-dependent effects of the ampakines Org 26576 and Org 24448 on local cerebral glucose utilisation in the mouse as assessed by 14C-2-deoxyglucose autoradiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Brain corticosteroid receptor balance in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

From inflammation to sickness and depression: when the immune system subjugates the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Association between depression and elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

The new biology of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

The relationship of depression and stressors to immunological assays: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Look who is weaving the neural web: glial control of synapse formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Oxytocin levels in the posterior pituitary and in the heart are modified by voluntary wheel running.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Cognitive deficits in depression: possible implications for functional neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Neural regulation of endocrine and autonomic stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

11 beta-Hydroxysteroid dehydrogenase activity and corticosteroid hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

The classical complement cascade mediates CNS synapse elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Hippocampal atrophy in recurrent major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Riluzole augmentation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Anhedonia and motivational deficits in rats: impact of chronic social stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

Interleukin 1 in the brain: biology, pathology and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

Aldosterone infusion into the rat and dose-dependent changes in blood pressure and arterial ionic transport

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

Treatment of premenstrual syndrome by spironolactone

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

Nontraditional aspects of aldosterone physiology

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

Inflammatory response following acute magnesium deficiency in the rat

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

The effects of ACTH on the renin-aldosterone system in normotensive man

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

Functional biology of intestinal goblet cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

Diurnal variations of plasma aldosterone in supine man: relationship to plasma renin activity and plasma cortisol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145711000368

7 January 2021

10.1017/S1461145711000368

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018